[
    [
        {
            "time": "",
            "original_text": "中银证券：10月金股组合收益10.54% 11月荐股名单出炉",
            "features": {
                "keywords": [
                    "中银证券",
                    "金股组合",
                    "收益",
                    "荐股名单"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中银证券：10月金股组合收益10.54% 11月荐股名单出炉",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "A股大逆转50强出炉，行业景气+业绩超预期，领涨龙头飙涨250%！机构预测这些股全年业绩高增长",
            "features": {
                "keywords": [
                    "A股",
                    "行业景气",
                    "业绩超预期",
                    "领涨龙头",
                    "机构预测",
                    "全年业绩高增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "多行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股大逆转50强出炉，行业景气+业绩超预期，领涨龙头飙涨250%！机构预测这些股全年业绩高增长",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【浙商医药|三季报】创新药研发高景气有望持续，看好CDMO业绩加速",
            "features": {
                "keywords": [
                    "浙商医药",
                    "三季报",
                    "创新药",
                    "高景气",
                    "CDMO",
                    "业绩加速"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【浙商医药|三季报】创新药研发高景气有望持续，看好CDMO业绩加速",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]